Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in... see more

TSXV:BTI.H - Post Discussion

View:
Post by prophetoffactz on Jan 04, 2023 9:14am

Zack's

Merger benefits include the enhanced scientific, technical and operational expertise that comes from combining the research teams and cost reductions from the elimination of duplicative salaries, administrative, regulatory and other public company expenses. Some of the primary benefits of the merger include:

Synergies from xB3 platform for use in Midatech’s lead program in DIPG

o Improved delivery via the SynchroMed II Pump

o Opportunity for new chemical entity and additional IP protection when employing xB3

Reduction in duplicative general and administrative expenses

Improved capital raising abilities with NASDAQ listing

Elimination of Lind debt from Bioasis’ balance sheet

Corporatewide focus on rare disease

o Enables small, cost-effective clinical trials

o Eligible for fast-track designation and early approval

Expanded experience and breadth of research and development team
BIOAF: Merger with Midatech Pharma (yahoo.com)

Comment by Boomskid on Jan 04, 2023 10:53am
Zacks is being paid by those who are benefitting most by one of the following: Check one of the following: [ ] Merger [ ] Acquisition [ ] Sellout [ ] Failure [ ] Theft. Zacks's diclosures from the article where poof got the clip he copy/pasted: DISCLOSURE: Zacks SCR has received compensation from the issuer directly, from an investment manager, or from an investor relations consulting firm, ...more  
Comment by narmac on Jan 04, 2023 1:20pm
Acccchhhhh,,nothing but more gobblygoook!!,,,,,,,VOTE NO,,,,,end the insanity!! Either hang onto our technology and take the NO Vote position,,,,,,or the collaberators on this one sided set up can enhance the deal to make it FAIR to BTI !!! Little fish dont eat big fish!!
Comment by G1945V on Jan 04, 2023 3:20pm
narmac, voting no on this deal would mean that BTI has to venture on its own for the foreseeable future. And the only way they can do that is to get substantial funding in place. Is BTI capable of drumming up enough interest to get the funding it needs to remain independent? One can only conclude that if new funding was available to BTI, this new (merger) arrangement that is coming to a vote ...more  
Comment by fuzzyjr on Jan 04, 2023 3:53pm
They have no plan B Gv.& if they do they best lay it out in short order. Who's going to run Bti & who's coming in with 4-5million to service debt & ongoing operations? Is there really someone out there seriously interested in taking this on knowing the many hurdles ahead- if there is what do u think they could possibly offer that would make ALL shareholders happy??  ...more  
Comment by Boomskid on Jan 04, 2023 6:39pm
There is no Plan B with a checkmate, fuzzy. Rathjen, the BoD, Lind, LT and The Placee set this up so that a Plan B is impossible. About being right, there is only one question and that is whether xB3 works or not. Of course LT and The Placee think it works and that it's worth a lot of money. That's why they made this deal. There is no other reason for players like this to put such an ...more  
Comment by MBT123 on Jan 04, 2023 10:28pm
It's very apparent BTI TO DA MOON GUY that it's BTI to grave...I have shares in this tire fire(FYI) All the signs were there for many years I ignored them all..Not a single person here can honestly believe it's valued at anymore than five pennies! If it was one of these "pharmas" would cut a cheque for 25 pennies and have it all no questions asked! Brokeguy threw the towel in ...more  
Comment by narmac on Jan 05, 2023 8:46am
,,To daa moon is right,,,,,unfortunately we got an astroid strike before lift off,,,,no one has next weeks news paper,,,,no one,,the circumstances around this company is all about our team being complacent coupled with their inexperience around Biotech drug launcing! Does the science work??,,,absolutely !!!,,and that is from the mouths of the research people!!,,so xB3 will make a tremendous amount ...more  
Comment by MBT123 on Jan 08, 2023 11:34pm
 Vote No then what??? Ride it down to zero pennies? I mean all your support of DrRatHen and MeiMei is great but writings on the wall bud!!! You and your buddies gonna call up J&J or Roche or Chisei or whoever and say please buy us for your coffee change .25!?? It's apparent it's .05 pennies maybe .10 if we're lucky..Not sure what your plans are or who ya know but I'm ...more  
Comment by narmac on Jan 09, 2023 6:10am
Hummmmm,,,,well if we are in such a dire situation then the rumblings behind the scene might come to fruition!..I hear a couple of larger shareholders talking and recommending a class action. Not that far off the mark when you think about it. I will continue the chat with these others. There maybe some interesting times ahead after all!!. The devil will be in the details. I am sure more discussion ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities